Lurasidone monotherapy for the treatment of bipolar I depression: results of a 6-week, double-blind, placebo-controlled study

被引：0
|
作者：
Loebel, A. [1 ]
Cucchiaro, J. [1 ]
Silva, R. [1 ]
Sarma, K. [1 ]
Kroger, H. [1 ]
Calabrese, J. R. [2 ]
Sachs, G. [3 ,4 ]
机构：
[1] Sunovion Pharmaceut Inc, Ft Lee, NJ USA
[2] Univ Hosp Case Med Ctr, Cleveland, OH USA
[3] Massachusetts Gen Hosp, Bipolar Clin, Boston, MA 02114 USA
[4] Massachusetts Gen Hosp, Res Program, Boston, MA 02114 USA
来源：
BIPOLAR DISORDERS | 2013年 / 15卷
关键词：
bipolar disorder; depression; atypical antipsychotics; randomized clinical trial;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：138 / 138
页数：1
相关论文
共 50 条
  • [31] Aripiprazole monotherapy in the treatment of acute bipolar I mania: A randomized, double-blind, placebo- and lithium-controlled study
    Keck, P. E.
    Orsulak, P. J.
    Cutler, A. J.
    Sanchez, R.
    Torbeyns, A.
    Marcus, R. N.
    McQuade, R. D.
    Carson, W. H.
    JOURNAL OF AFFECTIVE DISORDERS, 2009, 112 (1-3) : 36 - 49
  • [32] The direct and indirect effects of lurasidone monotherapy on functional improvement among patients with bipolar depression: results from a randomized placebo-controlled trial
    Rajagopalan, Krithika
    Bacci, Elizabeth Dansie
    Wyrwich, Kathleen W.
    Pikalov, Andrei
    Loebel, Antony
    INTERNATIONAL JOURNAL OF BIPOLAR DISORDERS, 2016, 4
  • [33] Olanzapine/Fluoxetine Combination in Children and Adolescents With Bipolar I Depression: A Randomized, Double-Blind, Placebo-Controlled Trial
    Detke, Holland C.
    DelBello, Melissa P.
    Landry, John
    Usher, Roland W.
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2015, 54 (03) : 217 - 224
  • [34] Divalproex in the treatment of bipolar depression: A placebo-controlled study
    Davis, LL
    Bartolucci, A
    Petty, F
    JOURNAL OF AFFECTIVE DISORDERS, 2005, 85 (03) : 259 - 266
  • [35] Quetiapine with lithium or divalproex for the treatment of bipolar mania: a randomized, double-blind, placebo-controlled study
    Sachs, G
    Chengappa, KNR
    Suppes, T
    Mullen, JA
    Brecher, M
    Devine, NA
    Sweitzer, DE
    BIPOLAR DISORDERS, 2004, 6 (03) : 213 - 223
  • [36] Maintenance therapy of aripiprazole vs. placebo in bipolar I disorder: a double-blind, placebo-controlled, 74-week extension of a 26-week study
    McIntyre, R. S.
    Keck, P.
    Calabrese, J.
    Momah, C.
    Carson, W.
    McQuade, R.
    Marcus, R.
    Carlson, B. X.
    Eudicone, J.
    Sanchez, R.
    BIPOLAR DISORDERS, 2007, 9 : 76 - 76
  • [37] The direct and indirect effects of lurasidone monotherapy on functional improvement among patients with bipolar depression: results from a randomized placebo-controlled trial
    Krithika Rajagopalan
    Elizabeth Dansie Bacci
    Kathleen W. Wyrwich
    Andrei Pikalov
    Antony Loebel
    International Journal of Bipolar Disorders, 4
  • [38] Quetiapine or haloperidol as monotherapy for bipolar mania - a 12-week, double-blind, randomised, parallel-group, placebo-controlled trial
    McIntyre, RS
    Brecher, M
    Paulsson, B
    Huizar, K
    Mullen, J
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 (05) : 573 - 585
  • [39] Efficacy and Safety of Cordyceps militaris as an Adjuvant to Duloxetine in the Treatment of Insomnia in Patients With Depression: A 6-Week Double- Blind, Randomized, Placebo-Controlled Trial
    Zhou, Jiaojiao
    Chen, Xu
    Xiao, Le
    Zhou, Jingjing
    Feng, Lei
    Wang, Gang
    FRONTIERS IN PSYCHIATRY, 2021, 12
  • [40] Double-blind, randomized, placebo-controlled trials of ethyl-eicosapentanoate in the treatment of bipolar depression and rapid cycling bipolar disorder
    Keck, Paul E., Jr.
    Mintz, Jim
    McElroy, Susan L.
    Freeman, Marlene P.
    Frye, Trisha Suppes Mark A.
    Altshuler, Lori L.
    Kupka, Ralph
    Nolen, Willem A.
    Leverich, Gabriele S.
    Denicoff, Kirk D.
    Grunze, Heinz
    Duan, Naihua
    Post, Robert M.
    BIOLOGICAL PSYCHIATRY, 2006, 60 (09) : 1020 - 1022
12345